Zuoming Xu

683 total citations
20 papers, 486 citations indexed

About

Zuoming Xu is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Zuoming Xu has authored 20 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 16 papers in Cancer Research and 2 papers in Cell Biology. Recurrent topics in Zuoming Xu's work include RNA modifications and cancer (14 papers), Cancer-related molecular mechanisms research (12 papers) and Cancer-related gene regulation (6 papers). Zuoming Xu is often cited by papers focused on RNA modifications and cancer (14 papers), Cancer-related molecular mechanisms research (12 papers) and Cancer-related gene regulation (6 papers). Zuoming Xu collaborates with scholars based in China and United States. Zuoming Xu's co-authors include Jianchu Wang, Huamei Wei, Wenchuan Li, Jian Pu, Xianjian Wu, Yuan Lu, Quan Fang, Ya Zhang, Yi Wu and Chuan Tan and has published in prestigious journals such as Scientific Reports, Journal of Cellular Physiology and Cell Death and Disease.

In The Last Decade

Zuoming Xu

19 papers receiving 480 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zuoming Xu China 12 387 313 73 59 53 20 486
Zhe Xuan China 9 525 1.4× 431 1.4× 85 1.2× 58 1.0× 56 1.1× 17 653
Cuiling Zeng China 9 443 1.1× 280 0.9× 48 0.7× 76 1.3× 69 1.3× 13 527
Zhonghai Guan China 8 280 0.7× 189 0.6× 43 0.6× 78 1.3× 41 0.8× 18 370
Liutao Chen China 7 445 1.1× 230 0.7× 24 0.3× 51 0.9× 38 0.7× 7 511
Juhong Wang China 12 419 1.1× 280 0.9× 35 0.5× 83 1.4× 50 0.9× 17 507
Guoli Shao China 11 249 0.6× 190 0.6× 44 0.6× 73 1.2× 42 0.8× 18 382
Chunbo Zhuang China 12 352 0.9× 293 0.9× 45 0.6× 38 0.6× 32 0.6× 19 445
Qiangnu Zhang China 12 277 0.7× 217 0.7× 29 0.4× 50 0.8× 65 1.2× 24 372
Shijia Yan China 7 250 0.6× 150 0.5× 71 1.0× 66 1.1× 36 0.7× 9 348

Countries citing papers authored by Zuoming Xu

Since Specialization
Citations

This map shows the geographic impact of Zuoming Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuoming Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuoming Xu more than expected).

Fields of papers citing papers by Zuoming Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zuoming Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuoming Xu. The network helps show where Zuoming Xu may publish in the future.

Co-authorship network of co-authors of Zuoming Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Zuoming Xu. A scholar is included among the top collaborators of Zuoming Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zuoming Xu. Zuoming Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Huamei, Min Zeng, Zheng Huang, et al.. (2025). m6A-modified CTC-297N7.9 inhibits hepatocellular carcinoma metastasis via epigenetically downregulating CCL2 and CD47. Cancer Cell International. 25(1). 290–290.
2.
3.
Li, Wenchuan, et al.. (2024). m6A-Methylated NUTM2B-AS1 Promotes Hepatocellular Carcinoma Stemness Feature via Epigenetically Activating BMPR1A Transcription. Journal of Hepatocellular Carcinoma. Volume 11. 2393–2411. 1 indexed citations
4.
Wei, Huamei, et al.. (2023). N6-Methyladenosine-Modified LEAWBIH Drives Hepatocellular Carcinoma Progression through Epigenetically Activating Wnt/β-Catenin Signaling. Journal of Hepatocellular Carcinoma. Volume 10. 1991–2007. 8 indexed citations
5.
Wei, Huamei, Zheng Huang, Min Zeng, et al.. (2023). m6A modification of AC026356.1 facilitates hepatocellular carcinoma progression by regulating the IGF2BP1-IL11 axis. Scientific Reports. 13(1). 19124–19124. 5 indexed citations
6.
Wu, Xianjian, et al.. (2023). HIF‑1α and RACGAP1 promote the progression of hepatocellular carcinoma in a mutually regulatory way. Molecular Medicine Reports. 28(5). 4 indexed citations
7.
Pu, Jian, Zuoming Xu, Meng Yang, et al.. (2023). N6‐methyladenosine‐modified FAM111A‐DT promotes hepatocellular carcinoma growth via epigenetically activating FAM111A. Cancer Science. 114(9). 3649–3665. 16 indexed citations
8.
Wei, Huamei, Zuoming Xu, Qing Wei, et al.. (2022). Long non-coding RNA PAARH promotes hepatocellular carcinoma progression and angiogenesis via upregulating HOTTIP and activating HIF-1α/VEGF signaling. Cell Death and Disease. 13(2). 102–102. 61 indexed citations
9.
Pu, Jian, Zuoming Xu, Quan Fang, et al.. (2021). M2 macrophage-derived extracellular vesicles facilitate CD8+T cell exhaustion in hepatocellular carcinoma via the miR-21-5p/YOD1/YAP/β-catenin pathway. Cell Death Discovery. 7(1). 182–182. 80 indexed citations
10.
11.
Pu, Jian, Ya Zhang, Anmin Wang, et al.. (2021). ADORA2A-AS1 Restricts Hepatocellular Carcinoma Progression via Binding HuR and Repressing FSCN1/AKT Axis. Frontiers in Oncology. 11. 754835–754835. 19 indexed citations
12.
Pu, Jian, Wenchuan Li, Anmin Wang, et al.. (2021). Long non-coding RNA HOMER3-AS1 drives hepatocellular carcinoma progression via modulating the behaviors of both tumor cells and macrophages. Cell Death and Disease. 12(12). 1103–1103. 22 indexed citations
13.
Wei, Huamei, Anmin Wang, Ya Zhang, et al.. (2021). lncRNA MAGI2-AS3 Exerts Antioncogenic Roles in Hepatocellular Carcinoma via Regulating the miR-519c-3p/TXNIP Axis. Journal of Oncology. 2021. 1–11. 7 indexed citations
14.
Pu, Jian, Jianchu Wang, An Min Wang, et al.. (2020). IGF2BP2 Promotes Liver Cancer Growth Through an m6A-FEN1-Dependent Mechanism. Frontiers in Oncology. 10. 578816–578816. 111 indexed citations
15.
Pu, Jian, Chuan Tan, Xianjian Wu, et al.. (2020). <p>Long Noncoding RNA <em>PART1</em> Promotes Hepatocellular Carcinoma Progression via Targeting miR-590-3p/<em>HMGB2</em> Axis</p>. OncoTargets and Therapy. Volume 13. 9203–9211. 16 indexed citations
16.
Lu, Yuan, et al.. (2020). SLC6A8 Knockdown Suppresses the Invasion and Migration of Human Hepatocellular Carcinoma Huh-7 and Hep3B Cells. Technology in Cancer Research & Treatment. 19. 1079250677–1079250677. 10 indexed citations
17.
Pu, Jian, Jianchu Wang, Zuoming Xu, et al.. (2019). miR-632 Functions as Oncogene in Hepatocellular Carcinoma via Targeting MYCT1. PubMed. 30(2). 67–73. 14 indexed citations
18.
Wei, Huamei, Jing Hu, Wenchuan Li, et al.. (2019). Long noncoding RNA HAGLROS promotes cell proliferation, inhibits apoptosis and enhances autophagy via regulating miR-5095/ATG12 axis in hepatocellular carcinoma cells. International Immunopharmacology. 73. 72–80. 54 indexed citations
19.
Wei, Huamei, Jianchu Wang, Zuoming Xu, et al.. (2019). miR‐584‐5p regulates hepatocellular carcinoma cell migration and invasion through targeting KCNE2. Molecular Genetics & Genomic Medicine. 7(6). e702–e702. 21 indexed citations
20.
Wang, Jianchu, Wenchuan Li, Zuoming Xu, et al.. (2018). The underlying pathophysiology association between the Type 2‐diabetic and hepatocellular carcinoma. Journal of Cellular Physiology. 234(7). 10835–10841. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhe Xuan Breakdown of academic impact, for papers by Cuiling Zeng Breakdown of academic impact, for papers by Zhonghai Guan Breakdown of academic impact, for papers by Liutao Chen Breakdown of academic impact, for papers by Juhong Wang Breakdown of academic impact, for papers by Guoli Shao Breakdown of academic impact, for papers by Chunbo Zhuang Breakdown of academic impact, for papers by Qiangnu Zhang Breakdown of academic impact, for papers by Shijia Yan
Rankless by CCL
2026